依达拉奉联合疏血通治疗急性脑出血的临床效果观察

To Observe the Clinical Effect of Edaravone Combined With Shuxuetong Injection in Treatment of Acute Cerebral Hemorrhage

目的：探究依达拉奉联合疏血通治疗急性脑出血的临床效果。方法选取2013年6月～2015年6月我院收治急性脑出血患者88例，随机分为两组，各44例。对照组采用疏血通治疗，观察组采用依达拉奉联合疏血通治疗，对比两组临床治疗有效率、治疗前后血液流变学和NIHSS评分对比。结果观察组总有效率和NIHSS评分高于对照组，差异显著（P＜0.05）；观察组治疗后全血粘度、血浆黏度和红细胞比容均明显优于对照组，差异显著（P＜0.05）。结论依达拉奉联合疏血通治疗急性脑出血患者临床效果显著，能够有效提高临床治疗有效率，改善患者血液流变学，降低神经功能缺损。

Objective To explore the clinical effect of edaravone combined with Shuxuetong injection in treatment of acute cerebral hemorrhage. MethodsFrom June 2013 to June 2015, 88 patients with acute cerebral hemorrhage were randomly divided into two groups, 44 cases in each group. Control group was treated with Shuxuetong treatment, the observation group with edaravone combined with Shuxuetong treatment, compared two groups of clinical treatment efficiency, before and after treatment, blood rheology, and NIHSS.Results In the observation group, the total efifciency and NIHSS score was signiifcantly higher than that of the control group, the difference was significant （P〈0.05）, treatment group were observed the whole blood viscosity, plasma viscosity and erythrocyte volume were significantly better than the control group, the difference was significant （P〈0.05）.Conclusion Edaravone combined with Shuxuetong injection in treatment of acute cerebral hemorrhage in patients with signiifcant clinical effect, can effectively improve the clinical treatment efficiency, improve blood rheology, decrease neurological deifcits.